cbdMD

Hemp-Derived CBD And Functional Beverages Will Drive Long-Term Market Share Gains

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

20 Dec 25

Views

n/a

AnalystConsensusTarget's Fair Value

n/a

-85.0%

-27.4%

-85.0%

-27.4%

You can edit this narrative until Dec 21 1:05 PM. Then, changes will post as Updates.

Author's Valuation

US$265.8% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

US$2

65.8% undervalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

5.75%

Pharma revenue growth rate

0.65%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.98%

Calculation

US$8.15m

Earnings '28

5.88x

PE Ratio '28

US$47.92m

Market Cap '28

US$47.92m

Market Cap '28

19.58m

No. shares '28

US$2.45

Share Price '28

US$2.45 Share Price '28

Discounted to 2025 @ 6.96% p.a.

US$2.00

Fair Value '25